Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Femasys Inc. Common Stock is a medical instruments & supplies business based in the US. Femasys IncCommon Stock shares (FEMY) are listed on the NASDAQ and all prices are listed in US Dollars. Femasys IncCommon Stock employs 25 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.00|
|52-week range||$6.50 - $13.75|
|50-day moving average||$7.18|
|200-day moving average||$7.55|
|Wall St. target price||$21.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.91|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-0.99%|
|1 month (2021-09-17)||-1.82%|
|3 months (2021-07-16)||-6.54%|
|6 months (2021-04-13)||N/A|
|1 year (2020-10-13)||N/A|
|2 years (2019-10-13)||N/A|
|3 years (2018-10-13)||N/A|
|5 years (2016-10-13)||N/A|
|Revenue TTM||$1.2 million|
|Gross profit TTM||$731,385|
|Return on assets TTM||0%|
|Return on equity TTM||-9999999%|
|Market capitalisation||$83.4 million|
TTM: trailing 12 months
There are currently 4,836 Femasys IncCommon Stock shares held short by investors – that's known as Femasys IncCommon Stock's "short interest". This figure is 64.4% down from 13,600 last month.
There are a few different ways that this level of interest in shorting Femasys IncCommon Stock shares can be evaluated.
Femasys IncCommon Stock's "short interest ratio" (SIR) is the quantity of Femasys IncCommon Stock shares currently shorted divided by the average quantity of Femasys IncCommon Stock shares traded daily (recently around 37200). Femasys IncCommon Stock's SIR currently stands at 0.13. In other words for every 100,000 Femasys IncCommon Stock shares traded daily on the market, roughly 130 shares are currently held short.
To gain some more context, you can compare Femasys IncCommon Stock's short interest ratio against those of similar companies.
However Femasys IncCommon Stock's short interest can also be evaluated against the total number of Femasys IncCommon Stock shares, or, against the total number of tradable Femasys IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Femasys IncCommon Stock's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Femasys IncCommon Stock shares in existence, roughly 0 shares are currently held short) or 0.0008% of the tradable shares (for every 100,000 tradable Femasys IncCommon Stock shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Femasys IncCommon Stock.
Find out more about how you can short Femasys IncCommon Stock stock.
We're not expecting Femasys IncCommon Stock to pay a dividend over the next 12 months.
Femasys Inc. , a biomedical company, researches, develops, and manufactures medical devices for the women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a sterile, single-use disposable endocervical curettage product; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.